Atlas Trials

A Study of Limited Heart Monitoring During Non-anthracycline Trastuzumab-based Therapy in Breast Cancer Patients

Clinical trial NCT03983382 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03983382
Sponsor
Memorial Sloan Kettering Cancer Center
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Breast Cancer
Start date
2019-03-22
Primary completion
2023-09-18
Enrollment
190

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.